Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18387444 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry
Conditions: Platelet Inhibition;   Coronary Stent Implantation
Interventions: Drug: prasugrel or ticagrelor;   Drug: Clopidogrel

Indicates status has not been verified in more than two years